| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8201013 | Reports of Practical Oncology & Radiotherapy | 2018 | 7 Pages |
Abstract
Of the selected patients, 80% had â¥81-95% of the Volrec within 100% of the prescribed dose and predominantly had central or in-field recurrences. These results are comparable with those from the literature.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Nuclear and High Energy Physics
Authors
Arno Lotar Cordova Jr., Taynná Vernalha Rocha Almeida, Cintia Mara da Silva, Pedro Argolo Piedade, Cristiane Maria Almeida, Carlos Genesio Bezzera Lima Jr., Carolina Dutra, Rafael Martins Ferreira, Marcelo Neves Linhares, Valeriy Denyak,